Abstract Submission FAQs and Guidelines - April 2022

Important Dates

Abstract Submission Opens
Monday, January 31, 2022

Abstract Submission Deadline
Monday, March 4, 2022

Poster Acceptance Notifications

Late Breaker Submission Deadline
Friday, March 11, 2022 (5:00 PM EST)

Oral Acceptance Notifications
Notification: Friday, March 18, 2022

Final Poster and Abstract for Virtual and/or In Person Posting
Friday, April 1, 2022 at 12:00 PM (EST)

The Poster Session will open for viewing on Saturday, April 9, 2022, at 5:00 PM EST.

Important Information Regarding Oral Presentations

Please be aware of the following dates and requirements in the event you have been selected:

A list of abstracts that have been accepted as oral presentations will be posted to the Conference Agenda.

  • April 1, 2022 - Presentations must be submitted for CME approval. Format will be MP4 or PPT for virtual presentations. There will be no extensions. More details to follow upon acceptance.
  • Frequently Asked Questions (FAQs)

    • Is there an abstract submission fee?
      Yes - US $50.00

      Is there a discounted rate for poster presenters to attend the conference?
      Yes - You will receive a discount code for US $50.00 off your registration fee and will need to register within 72 hours of acceptance notification in order to present your poster either virtually or in person.

      Are there rules about previous presentation of data?
      Encore presentations are permitted. All abstracts will undergo review by the Abstract Review Committee who will assess for scientific merit and novelty.

      Is a trial-in-progress abstract allowed?

      Is there an author limit for abstracts?

      Is there a word limit or character count to which we should adhere?
      700 words; 1 chart or graph is allowed

      May a non-author present on behalf of the authors?
      Yes, only if:
      • Presenter is not an employee of an industry sponsor
      • Presenter is a colleague attending the conference and presenting on behalf of authors who cannot attend

      Is Industry Sponsorship allowed?

      Is Society Sponsorship required for admission?

      Are QR codes allowed on the posters?

      Do you have any policy regarding the usage of brand names or trademarks in abstracts or posters?
      Brand names or trademarks are not allowed - only generic names may be used.

      Will you accept an abstract presenting only the study design?
      It would be preferable if the abstract included the results/read outs; however, if they are not available at the time of submission but will be presented at the conference, that would be acceptable.

      What are the Embargo Rules, if any?
      • None for encores.
      • For primary disclosures, scientific dissemination should be reserved until after the Conference. Press releases and media coverage are allowed in advance of the Conference.

      Where will the abstracts be published?
      All accepted abstracts will be published in the British Journal of Dermatology (BJD) as well as on the RAD Website. (Please note that BJD does not publish abstract charts or graphs.)

      What is the abstract notification date?
      Within approximately 1 week of abstract submission

      What is the pre-Conference abstract availability date/access venue?
      Saturday, April 9, 2022 - 5:00 PM EST - in person and on the RAD website

      What is the post-Conference abstract availability date/access venue?
      In perpetuity

      Is there a language requirement for the abstracts?

    Abstract Guidelines

    As you prepare your submission to the Conference, please make note of the following details:
    • All types of atopic dermatitis related research are eligible for submission.
    • Abstract should address scientific questions, detail clinical observations, or contain primary scientific data.
    • Encore presentations of data from previously presented research may be submitted.
    • Abstracts may be submitted in English only.

    Guidelines for Poster Presenters

    A pdf file will be required for online posting, and a 4' x 6' poster will be required in person.

    Presenting Author Responsibilities

    The presenting author must:

    • Agree to the Confidentiality Policy on behalf of all parties involved with the abstract and communicate this policy to all involved parties. The Confidentiality Policy applies to both standard and late-breaking data submission from the time of abstract submission.

    • Verify that, if necessary for the work reported, the clinical research represented in the abstract was approved by an appropriate ethics committee or institutional review board and that, if appropriate to the research, informed consent was obtained for all subjects.

    • Verify that all coauthors are aware of the contents of the abstract and support its data.

    • Agree, on behalf of all coauthors, to publication of the abstract in the final scientific program.

    • For an abstract to be included in the final scientific program, it is mandatory for the presenting author to register for the Conference and to settle payment within 72 hours of receiving the notification of abstract acceptance. A discount code for US $50.00 will be provided.

    • Agree to present the abstract if it is selected for poster presentation at the RAD Conference. This includes being present during the scheduled time of a poster session. Accepted posters will be accessible to delegates in the poster exhibition area as well as on the RAD website.

    • Agree to list all potential conflicts of interest in the poster presentation if the abstract is accepted for presentation at the RAD Conference.

    • Ensure that all coauthors meet the definition of authorship as stated by the International Committee of Medical Journal Editors.

    • Enter the name of the clinical trial registry and the trial registration number if the abstract reports on a registered clinical trial.
    © 2022 The Foundation for Dermatology Education.
    The Foundation for Dermatology Education is a registered 501(c)(3) nonprofit organization located in Chicago, IL.